Showing results (121-130 of 139) with videos related to

Sort By:
Pageof 14
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 1996
A randomised trial investigating the dose intensity of primary chemotherapy in patients with ovarian carcinoma: a comparison of chemotherapy given every four weeks with the same chemotherapy given at three week intervalsE Wrigley, A Weaver, G Jayson, et al.
British Journal of Cancer|April 1, 1985
Assay of anti-cancer drugs in tissue culture: relationship of relapse free interval (RFI) and in vitro chemosensitivity in patients with malignant cerebral gliomaD G Thomas, J L Darling, E A Paul, et al.
Neurology|August 1, 1997
Randomized, double-blind, placebo-controlled crossover trial of modafinil in the treatment of excessive daytime sleepiness in narcolepsyR J Broughton, J A Fleming, C F George, et al.
European Journal of Nuclear Medicine|March 18, 1999
Does salivary gland scintigraphy predict response to pilocarpine in patients with post-radiotherapy xerostomia?R A Cooper, R A Cowan, S E Owens, et al.
Neurogenetics|April 30, 2013
Peripheral blood gene expression signature differentiates children with autism from unaffected siblingsS W Kong, Y Shimizu-Motohashi, M G Campbell, et al.
Cancer Chemotherapy and Pharmacology|April 28, 2006
A phase I clinical and pharmacokinetic study of the multi-drug resistance protein-1 (MRP-1) inhibitor sulindac, in combination with epirubicin in patients with advanced cancerR O'Connor, M O'Leary, J Ballot, et al.
Irish Medical Journal|June 15, 2007
Sentinel lymph node biopsy in elderly irish patients with malignant melanomaD E Moran, M J Smith, M J O'Sullivan, et al.
Vascular Pharmacology|October 13, 2006
The application of genomic and proteomic technologies in predictive, preventive and personalized medicineC D Collins, S Purohit, R H Podolsky, et al.
Acta Oncologica (Stockholm, Sweden)|February 9, 2018
(ICORG 05-03): prospective randomized non-inferiority phase III trial comparing two radiation schedules in malignant spinal cord compression (not proceeding with surgical decompression); the quality of life analysisK A Lee, M Dunne, C Small, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|November 4, 2017
A Phase II Toxicity End Point Trial (ICORG 99-09) of Accelerated Dose-escalated Hypofractionated Radiation in Non-small Cell Lung CancerD N Cagney, P G Thirion, M T Dunne, et al.
Pageof 14